Clear 489 Results Filter Filter Results Type: Press Release Abiomed to Present at the 34th Annual JP Morgan Healthcare Conference Type: Press Release Abiomed Announces Q2 FY 2016 Revenue of $764 Million Up 47% Over Prior Year Type: Press Release Abiomeds Impella(R) Technology Showcased at TCT 2015 With Over 25 Presentations in the Scientific Sessions Type: Press Release Abiomed to Appoint Seth Bilazarian MD New Vice President of Interventional Cardiology Programs Type: Press Release Abiomed Second Quarter Fiscal 2016 Earnings and Conference Call Notification Type: Press Release Abiomed to Present at the Morgan Stanley Global Healthcare Conference Type: Press Release Abiomed Announces FDA Submission of Impella 25 Impella CP & Impella 50/LD Pre-Market Approval Supplements Type: Press Release Abiomed Announces Corporate Partnership With Fenway Park Brings Impella Mobile Learning Lab to Historic Stadium Type: Press Release Abiomed Outlines Long-Term Growth Strategy and Unveils Future Products at Annual Investor Conference Type: Press Release Abiomed to Hold Investor Day in Boston on August 11 … 14 15 16 17 …
